Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lymphoma, B-Cell × cemiplimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Melanoma 16 Neoplasm Metastasis 11 Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Recurrence 8 Skin Neoplasms 6 Ovarian Neoplasms 5 Carcinoma, Squamous Cell 5 Head and Neck Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Basal Cell 4 Triple Negative Breast Neoplasms 3 Multiple Myeloma 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Glioblastoma 2 Cutaneous Squamous Cell Carcinoma 2 Colonic Neoplasms 2 Carcinoma, Large Cell 2 Carcinoma 2

Interventions

Rituximab 38 Cyclophosphamide 23 ibrutinib 13 fludarabine 13 Vincristine 10 Prednisone 10 Doxorubicin 10 pirtobrutinib 9 obinutuzumab 8 Bendamustine Hydrochloride 8 polatuzumab vedotin 6 Inotuzumab Ozogamicin 6 pembrolizumab 5 glofitamab 5 ublituximab 4 tocilizumab 4 Gemcitabine 4 Brentuximab Vedotin 4 zanubrutinib 3 venetoclax 3 tazemetostat 3 Lenalidomide 3 Antigens, CD19 3 veltuzumab 2 iberdomide 2 denileukin diftitox 2 axicabtagene ciloleucel 2 acalabrutinib 2 Prednisolone 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02651662 2026-02-02

CLIO-1

Regeneron Pharmaceuticals

Phase 1 Active not recruiting

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡